Kyungpook National University Hospital clinical trials
Kyungpook National University Hospital is the lead sponsor of 6 current clinical trials in our South Korea register. 3 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are MFOLFOX6. The most-studied condition is Colon Cancer.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Kyungpook National University Hospital
6 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
The Treatment Effect for Asymptomatic Common Bile Duct Stone
NCT06215040 · ClinicalTrials.gov ↗ · Choledocholithiasis, Asymptomatic Condition, Quality of Life
|
Observational | Recruiting | 2024-01 | South Korea |
|
Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
NCT02193464 · ClinicalTrials.gov ↗ · Idiopathic Chronic Inflammatory Bowel Disease
|
Observational | Recruiting | 2014-09 | South Korea |
|
Analysis of Biomarkers From Patients With Chorioretinal Diseases
NCT02026843 · ClinicalTrials.gov ↗ · Diabetic Retinopathy, Macular Degeneration
|
Observational | Recruiting | 2012-04 | South Korea |
|
Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer
NCT05673772 · ClinicalTrials.gov ↗ · Rectal Cancer
Drug: MFOLFOX6 |
Phase 2 | Active, closed | 2020-10 | South Korea |
|
Early Commencement of Adjuvant Chemotherapy for Colon Cancer
NCT01460589 · ClinicalTrials.gov ↗ · Colon Cancer
|
Phase 3 | Active, closed | 2013-01 | South Korea |
|
Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
NCT03426904 · ClinicalTrials.gov ↗ · Colon Cancer
|
Phase 3 | Active, closed | 2020-10 | South Korea |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Kyungpook National University Hospital trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Kyungpook National University Hospital trials
8 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in South Korea | 6 | 3 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Colon Cancer
Sponsors with the most current trials registered for this condition.
Questions about Kyungpook National University Hospital trials
How many clinical trials does Kyungpook National University Hospital sponsor?
Kyungpook National University Hospital is the lead sponsor of 6 current trials on ClinicalTrials.gov in our South Korea register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.
Are Kyungpook National University Hospital trials recruiting?
Yes. 3 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Kyungpook National University Hospital testing?
Its current trials name 1 drug or biological as interventions. The most frequent are MFOLFOX6 (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.